Henry Schein will gain exclusive U.S. distribution rights for Curodont across all dental market segments beginning January 1, 2026.
Henry Schein Inc announced that it will expand its agreement with vVARDIS to become the exclusive U.S. distributor of the Curodont Repair Fluoride Plus product across all dental market segments, effective January 1, 2026.
Expansion to Cover Entire U.S. Dental Market
The expansion builds on a 2024 agreement between the companies that granted Henry Schein exclusive distribution rights to Dental Service Organizations. The new agreement will extend that exclusivity to include general dentistry, orthodontics, and pediatric dentistry practices nationwide.
“We are pleased to build upon our existing relationship with vVARDIS, the company behind a product that has seen remarkable success and growth in the dental industry,” said Stanley M. Bergman, chairman of the board and CEO of Henry Schein. “This expansion is a testament to our shared commitment of helping dental professionals operate more efficient practices, all while advancing the oral and overall health of their communities.”
Drill-Free Caries Treatment for Early-Stage Cavities
Curodont is a proprietary product that treats early-stage cavities without drilling or needles. According to the International Journal of Epidemiology, individuals with untreated cavities face a higher risk of all-cause and heart disease mortality. Up to 80% of patients present with early-stage cavities, and most have historically left dental offices untreated. Curodont provides a treatment option to help practices address this gap in care.
vVARDIS Cites Product Growth and Adoption
“Our decision to broaden the relationship with Henry Schein was driven by the exceptional success we have already achieved, having accessed over 10% of U.S. dental offices and having treated more than 500,000 patients,” said Drs. Haley and Goly Abivardi, DMDs, founders and Co-CEOs of vVARDIS. “The foundation of trust, shared goals, and delivered growth made it clear that Henry Schein is the right partner to make Curodont accessible to the entire U.S. dental community.”
Henry Schein’s Market Position
Henry Schein is currently the market leader in U.S. sales of Curodont to general practitioners and DSOs. It is also the exclusive distributor of the product in the United Kingdom and holds non-exclusive rights in other regions.
Photo: ID 10221984 © Pressmaster | Dreamstime.com
